4,6,8-Decatrienamide,3-hydroxy-2,2,4-trimethyl-10-(5-oxazolyl)-, (3R,4Z,6Z,8E)- (130288-22-1)

Identification
Name:	4,6,8-Decatrienamide,3-hydroxy-2,2,4-trimethyl-10-(5-oxazolyl)-, (3R,4Z,6Z,8E)-
Synonyms:	4,6,8-Decatrienamide,3-hydroxy-2,2,4-trimethyl-10-(5-oxazolyl)-, [R-(Z,Z,E)]-; CL 22T; Inthomycin A;Phthoxazolin; Phthoxazolin A
CAS:	130288-22-1
Molecular Formula:	C16H22 N2 O3
Molecular Weight:	0
InChI:	InChI=1/C16H22N2O3/c1-12(14(19)16(2,3)15(17)20)8-6-4-5-7-9-13-10-18-11-21-13/h4-8,10-11,14,19H,9H2,1-3H3,(H2,17,20)/b6-4-,7-5+,12-8-/t14-/m1/s1
Molecular Structure:
Properties
Flash Point:	275°C
Boiling Point:	531.1°C at 760 mmHg
Density:	1.12g/cm³
Refractive index:	1.546
Flash Point:	275°C
Safety Data

Other Product

4,6,8-Decatrienamide,3-hydroxy-N-[(2E,4E,- 6R,7R,9S)-6-hydroxy-9-[(4S,7R,8S)-8- hydroxy-5,7-dimethyl-1,6-dioxo-2-oxa-5- azaspiro[3.4]oct-8-yl]-9-methoxy-7-methyl- 2,4-nonadienyl]-2,2,4-trimethyl-10-(5-oxazolyl)-,(3R,4E,6E,8E)-
4,6,8-Decatrienamide,3-hydroxy-2,2,4-trimethyl-10-(5-oxazolyl)- (9CI)
4,6,8-Decatrienamide,3-hydroxy-N-[6-hydroxy-9-(8-hydroxy-1,5,7-trimethyl-3,6-dioxo-2-oxa-5-azaspiro[3.4]oct-8-yl)-9-methoxy-7-methyl-2,4-nonadienyl]-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-(9CI)
4,6,8-Decatrienamide,3-hydroxy-N-[6-hydroxy-9-[8-hydroxy-1-(methoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-azaspiro[3.4]oct-8-yl]-9-methoxy-7-methyl-2,4-nonadienyl]-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-(9CI)
4,6,8-decatrienamide, 3-hydroxy-N-(6-hydroxy-9-(8-hydroxy-1-(methyoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-asaspiro(3.4)oct-8-yl)-9-methyl-2,4-nonadienyl)-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-
4,6,8,10-Undecatetraen-3-one,5-hydroxy-2,- 10-dimethyl-11-(1H-pyrrol-2-yl)-,(4Z,6Z,- 8E,10E)-
4,6,8-Decatrienoic acid, 3-hydroxy-2,2,4-trimethyl-10-phenyl-,(4Z,6Z,8E)-
2,6,8-Decatrienamide,N-(2-methylpropyl)-, (2E,6Z,8E)-
8-Decen-5-one, 3-hydroxy-7-[(4-methoxyphenyl)methoxy]-2-methyl-,(3R,7R,8E)-rel-
1-Oxa-7-azaspiro[5.5]undecan-8-one,2-[(2R,- 3R,6E,8E,10S,12E,14E)-2,10-dihydroxy-3,9- dimethyl-15-[(2S,3R,4R,5R)-tetrahydro-4- hydroxy-3-methyl-6-oxo-5-(3-oxobutyl)- 2H-pyran-2-yl]-6,8,12,14-pentadecatetraenyl]- 9-ethyl-4-hydroxy-3,5,11- trimethyl-,(2S,3R,4S,5S,6R,9S,11S)-
b-D-Galactopyranoside,(1S,3'R,4'R,5'R,6'R)-3',4',5',6'-tetrahydro-3',5,7-trihydroxy-4'-[[(2E,4E,8E,10E)-7-hydroxy-8,14-dimethyl-1-oxo-2,4,8,10-hexadecatetraenyl]oxy]-6'-(hydroxymethyl)spiro[isobenzofuran-1(3H),2'-[2H]pyran]-5'-yl,6-[(2E,4Z,6E)-8-hydroxy-2,4,6-decatrienoate] (9CI)
(3aR,4R,6Z,8S,10E,11aR)-8-hydroxy-6-(hydroxymethyl)-10-methyl-3-methylidene-2-oxo-2,3,3a,4,5,8,9,11a-octahydrocyclodeca[b]furan-4-yl (2Z)-2-methylbut-2-enoate
4,6,8-Decatrienoic acid, 3-hydroxy-2,2,4-trimethyl-10-phenyl-, ethylester, (4Z,6E,8E)-
4,6,8-Decatrienoic acid, 3-hydroxy-2,2,4-trimethyl-10-phenyl-, ethylester, (4Z,8E)-
2-Methylpropenoic acid [(3aR,4R,6Z,8S,10E,11aR)-2,3,3a,4,5,8,9,11a-octahydro-8-hydroxy-6-hydroxymethyl-10-methyl-3-methylene-2-oxocyclodeca[b]furan-4-yl] ester
1H-Benz[e]indene-6-propanoicacid,3-[(1R,4Z)-1-carboxy-6-hydroxy-5-methyl-4-hexen-1-yl]-2,3,3a,4,6,7,8,9b-octahydro-2-hydroxy-3a,6,9b-trimethyl-7-(1-methylethenyl)-,(2R,3R,3aR,6S,7S,9bR)-
2-Hexynoic acid,4-hydroxy-6-[2-[(2S,3R)-3-(iodomethyl)-1-(triphenylmethyl)-2-aziridinyl]-5-oxazolyl]-, methyl ester
2,4,6,8-Dodecatetraenedioicacid, 10-hydroxy-5,9,11-trimethyl-,12-[(3R,4aR,8S,10S,10aS,10bR)-2,3,4a,8,9,10,10a,10b-octahydro-3-hydroxy-4a,8,10b-trimethyl-1-oxo-1H-naphtho[2,1-b]pyran-10-yl]ester, (2E,4Z,6E,8E,10R,11S)-
(2E,4E,6E,8E)-10-({(3R,4S,5S,6R)-5-methoxy-4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]oct-6-yl}oxy)-10-oxodeca-2,4,6,8-tetraenoic acid
6,10-Dodecadienoicacid, 6-[(acetyloxy)methyl]-12-hydroxy-10-methyl-2-(4-methyl-3-penten-1-yl)-,(6Z,10E)-